{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:57:00Z","timestamp":1791341820578,"version":"4.3.1"},"reference-count":175,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T00:00:00Z","timestamp":1614211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000861","name":"Burroughs Wellcome Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000861","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Giant cell arteritis (GCA) is a granulomatous systemic vasculitis of large- and medium-sized arteries that affects the elderly. In recent years, advances in diagnostic imaging have revealed a greater degree of large vessel involvement than previously recognized, distinguishing classical cranial- from large vessel (LV)- GCA. GCA often co-occurs with the poorly understood inflammatory arthritis\/bursitis condition polymyalgia rheumatica (PMR) and has overlapping features with other non-infectious granulomatous vasculitides that affect the aorta, namely Takayasu Arteritis (TAK) and the more recently described clinically isolated aortitis (CIA). Here, we review the literature focused on the immunopathology of GCA on the background of the three settings in which comparisons are informative: LV and cranial variants of GCA; PMR and GCA; the three granulomatous vasculitides (GCA, TAK, and CIA). We discuss overlapping and unique features between these conditions across clinical presentation, epidemiology, imaging, and conventional histology. We propose a model of GCA where abnormally activated circulating cells, especially monocytes and CD4<jats:sup>+<\/jats:sup>T cells, enter arteries after an unknown stimulus and cooperate to destroy it and review the evidence for how this mechanistically occurs in active disease and improves with treatment.<\/jats:p>","DOI":"10.3389\/fimmu.2021.623716","type":"journal-article","created":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T05:23:27Z","timestamp":1614230607000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":52,"title":["The Immunopathology of Giant Cell Arteritis Across Disease Spectra"],"prefix":"10.3389","volume":"12","author":[{"given":"Michelle L.","family":"Robinette","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak A.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Monach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,2,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised international chapel hill consensus conference nomenclature of vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum."},{"key":"B2","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1093\/rheumatology\/kew273","article-title":"The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease","volume":"56","author":"Dejaco","year":"2017","journal-title":"Rheumatology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/1529-0131(199902)42:2<311::AID-ANR14>3.0.CO;2-F","article-title":"Disease pattern in cranial and large-vessel giant cell arteritis","volume":"42","author":"Brack","year":"1999","journal-title":"Arthritis Rheum."},{"key":"B4","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/j.0954-6820.1972.tb15615.x","article-title":"Morphological changes in the large arteries in polymyalgia arteritica","volume":"533","author":"Ostberg","year":"1972","journal-title":"Acta Med Scand Suppl."},{"key":"B5","doi-asserted-by":"publisher","first-page":"806","DOI":"10.7326\/0003-4819-83-6-806","article-title":"Large artery involvement in giant cell (temporal) arteritis","volume":"83","author":"Klein","year":"1975","journal-title":"Ann Intern Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"ii32","DOI":"10.1093\/rheumatology\/kex424","article-title":"Large-vessel giant cell arteritis: diagnosis, monitoring and management","volume":"57","author":"Koster","year":"2018","journal-title":"Rheumatology"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1002\/art.1780330810","article-title":"The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis","volume":"33","author":"Hunder","year":"1990","journal-title":"Arthritis Rheum"},{"key":"B8","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1002\/art.34356","article-title":"2012 Provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism\/American College of Rheumatology collaborative initiative","volume":"64","author":"Dasgupta","year":"2012","journal-title":"Arthritis Rheum."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.1002\/art.22754","article-title":"Adjunctive methotrexate for treatment of giant cell arteritis: an individual patient data meta-analysis","volume":"56","author":"Mahr","year":"2007","journal-title":"Arthritis Rheum."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1016\/S0140-6736(16)00560-2","article-title":"Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial","volume":"387","author":"Villiger","year":"2016","journal-title":"Lancet."},{"key":"B11","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1056\/NEJMoa1613849","article-title":"Trial of tocilizumab in giant-cell arteritis","volume":"377","author":"Stone","year":"2017","journal-title":"N Engl J Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"iii17","DOI":"10.1093\/rheumatology\/kez645","article-title":"Treatment of giant-cell arteritis: from broad spectrum immunosuppressive agents to targeted therapies","volume":"59","author":"Cid","year":"2020","journal-title":"Rheumatology"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1002\/art.1780330811","article-title":"The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis","volume":"33","author":"Arend","year":"1990","journal-title":"Arthritis Rheum"},{"key":"B14","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.carpath.2017.04.003","article-title":"Clinically isolated aortitis: pitfalls, progress, and possibilities","volume":"29","author":"Cinar","year":"2017","journal-title":"Cardiovasc Pathol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1161\/01.CIR.0000066907.83923.32","article-title":"Elevated production of interleukin-6 is associated with a lower incidence of disease-related ischemic events in patients with giant-cell arteritis: angiogenic activity of interleukin-6 as a potential protective mechanism","volume":"107","author":"Hernandez-Rodriguez","year":"2003","journal-title":"Circulation"},{"key":"B16","doi-asserted-by":"publisher","first-page":"rkz011","DOI":"10.1093\/rap\/rkz011","article-title":"Interleukin-6 does not upregulate pro-inflammatory cytokine expression in an ex vivo model of giant cell arteritis","volume":"3","author":"O'Neill","year":"2019","journal-title":"Rheumatol Adv Pract."},{"key":"B17","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1001\/jama.1957.02970450023007","article-title":"Treatment of temporal arteritis with adrenal corticosteroids; results in fifty-five cases in which lesion was proved at biopsy","volume":"163","author":"Birkhead","year":"1957","journal-title":"J Am Med Assoc."},{"key":"B18","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/0002-9394(58)92165-2","article-title":"The ocular lesions of temporal arteritis","volume":"45","author":"Wagener","year":"1958","journal-title":"Am J Ophthalmol."},{"key":"B19","first-page":"182","article-title":"Extracranial giant cell arteritis: a narrative review","volume":"74","author":"Lensen","year":"2016","journal-title":"Neth J Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.semarthrit.2018.05.007","article-title":"Predictors of positive (18)F-FDG PET\/CT-scan for large vessel vasculitis in patients with persistent polymyalgia rheumatica","volume":"48","author":"Prieto-Pena","year":"2019","journal-title":"Semin Arthritis Rheum."},{"key":"B21","first-page":"470","article-title":"Giant cell arteritis presenting as limb claudication. Report and review of the literature","volume":"18","author":"Walz-Leblanc","year":"1991","journal-title":"J Rheumatol."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2020.11.003","article-title":"Prevalence and prognostic factors for aortic dilatation in giant cell arteritis - a longitudinal study","author":"Jud","year":"2020","journal-title":"Semin Arthritis Rheum."},{"key":"B23","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1136\/annrheumdis-2012-202145","article-title":"Should I send my patient with previous giant cell arteritis for imaging of the thoracic aorta? A systematic literature review and meta-analysis","volume":"73","author":"Mackie","year":"2014","journal-title":"Ann Rheum Dis."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1080\/03009742.2020.1786855","article-title":"Incidence and predictors of thoracic aortic damage in biopsy-proven giant cell arteritis","author":"Koster","year":"2020","journal-title":"Scand J Rheumatol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1007\/s40266-019-00705-5","article-title":"Pathogenesis, diagnosis and management of polymyalgia rheumatica","volume":"36","author":"Camellino","year":"2019","journal-title":"Drugs Aging."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.semarthrit.2020.05.023","article-title":"A seasonal pattern in the onset of polymyalgia rheumatica and giant cell arteritis? A systematic review and meta-analysis","volume":"50","author":"Hysa","year":"2020","journal-title":"Semin Arthritis Rheum."},{"key":"B27","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1002\/art.20227","article-title":"Reappraisal of the epidemiology of giant cell arteritis in Olmsted County, Minnesota, over a fifty-year period","volume":"51","author":"Salvarani","year":"2004","journal-title":"Arthritis Rheum."},{"key":"B28","doi-asserted-by":"publisher","first-page":"S170","DOI":"10.1016\/j.jtcvs.2014.08.003","article-title":"Inflammatory disease of the aorta: patterns and classification of giant cell aortitis, Takayasu arteritis, and nonsyndromic aortitis","volume":"149","author":"Svensson","year":"2015","journal-title":"J Thorac Cardiovasc Surg."},{"key":"B29","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/1756-185X.13288","article-title":"Takayasu arteritis and giant cell arteritis: are they a spectrum of the same disease?","volume":"1","author":"Kermani","year":"2019","journal-title":"Int J Rheum Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.autrev.2017.11.029","article-title":"Large-vessel involvement and aortic dilation in giant-cell arteritis. A multicenter study of 549 patients","volume":"17","author":"de Boysson","year":"2018","journal-title":"Autoimmun Rev."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1002\/art.1780261007","article-title":"The epidemiology of giant cell arteritis. Report of a ten-year study in Shelby County, Tennessee","volume":"26","author":"Smith","year":"1983","journal-title":"Arthritis Rheum."},{"key":"B32","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1002\/art.11195","article-title":"Clinical and epidemiologic analysis of giant cell (temporal) arteritis from a nationwide survey in 1998 in Japan: the first government-supported nationwide survey","volume":"49","author":"Kobayashi","year":"2003","journal-title":"Arthritis Rheum."},{"key":"B33","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3129\/i08-164","article-title":"Giant cell arteritis in Alaska Natives","volume":"44","author":"Mader","year":"2009","journal-title":"Can J Ophthalmol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1001\/archinte.149.7.1561","article-title":"Giant-cell arteritis in the southern United States. An 11-year retrospective study from the Texas Gulf Coast","volume":"149","author":"Gonzalez","year":"1989","journal-title":"Arch Intern Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/eye.2016.199","article-title":"Ophthalmic presentation of giant cell arteritis in African-Americans","volume":"31","author":"Garrity","year":"2017","journal-title":"Eye"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1001\/jamaophthalmol.2019.2919","article-title":"Association of giant cell arteritis with race","volume":"137","author":"Gruener","year":"2019","journal-title":"JAMA Ophthalmol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1002\/acr.23897","article-title":"Determinants of positive temporal artery biopsies in the veterans health administration national database cohort","volume":"72","author":"Chung","year":"2020","journal-title":"Arthritis Care Res"},{"key":"B38","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.rdc.2020.07.001","article-title":"Racial disparities in rheumatology through the lens of critical race theory","volume":"46","author":"Williams","year":"2020","journal-title":"Rheum Dis Clin North Am."},{"key":"B39","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s11926-019-0848-3","article-title":"Takayasu arteritis: recent developments","volume":"21","author":"Zaldivar Villon","year":"2019","journal-title":"Curr Rheumatol Rep."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1016\/j.athoracsur.2008.07.039","article-title":"Incidence, etiology, histologic findings, and course of thoracic inflammatory aortopathies","volume":"86","author":"Pacini","year":"2008","journal-title":"Ann Thorac Surg."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1172\/JCI116125","article-title":"The HLA-DRB1 locus as a genetic component in giant cell arteritis. Mapping of a disease-linked sequence motif to the antigen binding site of the HLA-DR molecule","volume":"90","author":"Weyand","year":"1992","journal-title":"J Clin Invest."},{"key":"B42","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.semarthrit.2003.12.001","article-title":"HLA-DRB1 allele distribution in polymyalgia rheumatica and giant cell arteritis: influence on clinical subgroups and prognosis","volume":"34","author":"Martinez-Taboda","year":"2004","journal-title":"Semin Arthritis Rheum."},{"key":"B43","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1002\/art.1780370411","article-title":"HLA-DRB1 alleles in polymyalgia rheumatica, giant cell arteritis, and rheumatoid arthritis","volume":"37","author":"Weyand","year":"1994","journal-title":"Arthritis Rheum."},{"key":"B44","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1093\/rheumatology\/35.7.632","article-title":"Polymyalgia rheumatica is associated with both HLA-DRB1*0401 and DRB1*0404","volume":"35","author":"Haworth","year":"1996","journal-title":"Br J Rheumatol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.ajhg.2013.05.026","article-title":"Identification of multiple genetic susceptibility loci in Takayasu arteritis","volume":"93","author":"Saruhan-Direskeneli","year":"2013","journal-title":"Am J Hum Genet"},{"key":"B46","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.ajhg.2015.02.009","article-title":"A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility","volume":"96","author":"Carmona","year":"2015","journal-title":"Am J Hum Genet."},{"key":"B47","doi-asserted-by":"publisher","first-page":"43953","DOI":"10.1038\/srep46012","article-title":"Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy","volume":"7","author":"Carmona","year":"2017","journal-title":"Sci Rep."},{"key":"B48","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1080\/14397595.2019.1570999","article-title":"Difference in immunohistochemical characteristics between Takayasu arteritis and giant cell arteritis: it may be better to distinguish them in the same age","volume":"29","author":"Kurata","year":"2019","journal-title":"Mod Rheumatol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.semarthrit.2018.04.004","article-title":"Ustekinumab for refractory giant cell arteritis: a prospective 52-week trial","volume":"48","author":"Conway","year":"2018","journal-title":"Semin Arthritis Rheum."},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1002\/acr.24378","article-title":"Ustekinumab for the treatment of giant cell arteritis","author":"Matza","year":"2020","journal-title":"Arthritis Care Res"},{"key":"B51","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1136\/annrheumdis-2017-212649","article-title":"EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice","volume":"77","author":"Dejaco","year":"2018","journal-title":"Ann Rheum Dis."},{"key":"B52","doi-asserted-by":"publisher","first-page":"e000612","DOI":"10.1136\/rmdopen-2017-000612","article-title":"Imaging in diagnosis, outcome prediction and monitoring of large vessel vasculitis: a systematic literature review and meta-analysis informing the EULAR recommendations","volume":"4","author":"Duftner","year":"2018","journal-title":"RMD Open."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1002\/art.40864","article-title":"Diagnostic accuracy of positron emission tomography\/computed tomography of the head, neck, and chest for giant cell arteritis: a prospective, double-blind, cross-sectional study","volume":"71","author":"Sammel","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"e4146","DOI":"10.1097\/MD.0000000000004146","article-title":"Positron emission tomography and computed tomography angiography for the diagnosis of giant cell arteritis: a real-life prospective study","volume":"95","author":"Lariviere","year":"2016","journal-title":"Medicine"},{"key":"B55","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1148\/radiol.14140056","article-title":"Giant cell arteritis: diagnostic accuracy of MR imaging of superficial cranial arteries in initial diagnosis-results from a multicenter trial","volume":"273","author":"Klink","year":"2014","journal-title":"Radiology."},{"key":"B56","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/art.39824","article-title":"High-resolution magnetic resonance imaging of scalp arteries for the diagnosis of giant cell arteritis: results of a prospective cohort study","volume":"69","author":"Rheaume","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1093\/rheumatology\/38.5.444","article-title":"New arguments for a vasculitic nature of polymyalgia rheumatica using positron emission tomography","volume":"38","author":"Blockmans","year":"1999","journal-title":"Rheumatology"},{"key":"B58","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/art.21699","article-title":"Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients","volume":"55","author":"Blockmans","year":"2006","journal-title":"Arthritis Rheum."},{"key":"B59","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1093\/rheumatology\/kel376","article-title":"Repetitive 18-fluorodeoxyglucose positron emission tomography in isolated polymyalgia rheumatica: a prospective study in 35 patients","volume":"46","author":"Blockmans","year":"2007","journal-title":"Rheumatology"},{"key":"B60","doi-asserted-by":"publisher","first-page":"705","DOI":"10.3109\/s10165-011-0581-x","article-title":"Whole-body fluorodeoxyglucose positron emission tomography\/computed tomography in patients with active polymyalgia rheumatica: evidence for distinctive bursitis and large-vessel vasculitis","volume":"22","author":"Yamashita","year":"2012","journal-title":"Mod Rheumatol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"20170198","DOI":"10.1259\/bjr.20170198","article-title":"(18)F-FDG PET\/CT in polymyalgia rheumatica-a pictorial review","volume":"90","author":"Rehak","year":"2017","journal-title":"Br J Radiol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.remn.2015.05.011","article-title":"(18)F-FDG PET\/CT for the detection of large vessel vasculitis in patients with polymyalgia rheumatica","volume":"34","author":"Lavado-Perez","year":"2015","journal-title":"Rev Esp Med Nucl Imagen Mol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1136\/annrheumdis-2013-204572","article-title":"Positron emission tomography assessment of large vessel inflammation in patients with newly diagnosed, biopsy-proven giant cell arteritis: a prospective, case-control study","volume":"73","author":"Prieto-Gonzalez","year":"2014","journal-title":"Ann Rheum Dis."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1007\/s00259-018-4021-4","article-title":"Three days of high-dose glucocorticoid treatment attenuates large-vessel 18F-FDG uptake in large-vessel giant cell arteritis but with a limited impact on diagnostic accuracy","volume":"45","author":"Nielsen","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"B65","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3899\/jrheum.181222","article-title":"Effect of treatment on imaging, clinical, and serologic assessments of disease activity in large-vessel vasculitis","volume":"47","author":"Banerjee","year":"2020","journal-title":"J Rheumatol."},{"key":"B66","first-page":"S47","article-title":"[18F] FDG-PET\/CT as a new and sensitive imaging method for the diagnosis of large vessel vasculitis","volume":"26","author":"Henes","year":"2008","journal-title":"Clin Exp Rheumatol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1111\/1756-185X.13805","article-title":"Cranial and large vessel activity on positron emission tomography scan at diagnosis and 6 months in giant cell arteritis","volume":"23","author":"Sammel","year":"2020","journal-title":"Int J Rheum Dis."},{"key":"B68","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1002\/art.40379","article-title":"(18) F-fluorodeoxyglucose-positron emission tomography as an imaging biomarker in a prospective, longitudinal cohort of patients with large vessel vasculitis","volume":"70","author":"Grayson","year":"2018","journal-title":"Arthritis Rheumatol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1136\/annrheumdis-2018-213102","article-title":"Comparison of magnetic resonance angiography and (18)F-fluorodeoxyglucose positron emission tomography in large-vessel vasculitis","volume":"77","author":"Quinn","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1093\/rheumatology\/kez058.023","article-title":"Patterns of arterial disease in Takayasu's arteritis and giant cell arteritis","volume":"72","author":"Gribbons","year":"2019","journal-title":"Arthritis Care Res"},{"key":"B71","doi-asserted-by":"publisher","first-page":"21","DOI":"10.17305\/bjbms.2019.4320","article-title":"Pathogenesis of atherosclerosis in the tunica intima, media, and adventitia of coronary arteries: an updated review","volume":"20","author":"Milutinovic","year":"2020","journal-title":"Bosn J Basic Med Sci."},{"key":"B72","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1146\/annurev-physiol-030212-183802","article-title":"The adventitia: essential regulator of vascular wall structure and function","volume":"75","author":"Stenmark","year":"2013","journal-title":"Annu Rev Physiol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1016\/S0002-9440(10)64458-6","article-title":"Trapping of misdirected dendritic cells in the granulomatous lesions of giant cell arteritis","volume":"161","author":"Krupa","year":"2002","journal-title":"Am J Pathol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3899\/jrheum.100455","article-title":"Temporal small-vessel inflammation in patients with giant cell arteritis: clinical course and preliminary immunohistopathologic characterization","volume":"38","author":"Belilos","year":"2011","journal-title":"J Rheumatol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00005792-197101000-00001","article-title":"Giant cell arteritis: including temporal arteritis and polymyalgia rheumatica","volume":"50","author":"Hamilton","year":"1971","journal-title":"Medicine"},{"key":"B76","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/j.1699-0463.1987.tb00039_95A.x","article-title":"Giant-cell arteritis. Histological, immunohistochemical and electronmicroscopic studies","volume":"95","author":"Chemnitz","year":"1987","journal-title":"Acta Pathol Microbiol Immunol Scand A."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1002\/art.1780330804","article-title":"Illustrated histopathologic classification criteria for selected vasculitis syndromes. American College of Rheumatology Subcommittee on Classification of Vasculitis","volume":"33","author":"Lie","year":"1990","journal-title":"Arthritis Rheum."},{"key":"B78","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/S0161-6420(86)33706-0","article-title":"Temporal arteritis. A clinicopathologic study","volume":"93","author":"McDonnell","year":"1986","journal-title":"Ophthalmology."},{"key":"B79","doi-asserted-by":"publisher","first-page":"2674","DOI":"10.1002\/1529-0131(199912)42:12<2674::AID-ANR25>3.0.CO;2-A","article-title":"Temporal artery biopsy: a diagnostic tool for systemic necrotizing vasculitis. French Vasculitis Study Group","volume":"42","author":"Genereau","year":"1999","journal-title":"Arthritis Rheum."},{"key":"B80","doi-asserted-by":"publisher","first-page":"139163","DOI":"10.1172\/jci.insight.139163","article-title":"ROS-producing immature neutrophils in giant cell arteritis are linked to vascular pathologies","volume":"5","author":"Wang","year":"2020","journal-title":"JCI Insight."},{"key":"B81","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/S0049-0172(95)80010-7","article-title":"Aortic and extracranial large vessel giant cell arteritis: a review of 72 cases with histopathologic documentation","volume":"24","author":"Lie","year":"1995","journal-title":"Semin Arthritis Rheum."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.semarthrit.2020.05.021","article-title":"Significance of inflammation restricted to adventitial\/periadventitial tissue on temporal artery biopsy","volume":"50","author":"Galli","year":"2020","journal-title":"Semin Arthritis Rheum."},{"key":"B83","first-page":"258","article-title":"Significance of isolated vasculitis of the vasa vasorum on temporal artery biopsy","volume":"21","author":"Disdier","year":"1994","journal-title":"J Rheumatol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.3899\/jrheum.170061","article-title":"Poor predictive value of isolated adventitial and periadventitial infiltrates in temporal artery biopsies for diagnosis of giant cell arteritis","volume":"44","author":"Le Pendu","year":"2017","journal-title":"J Rheumatol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1097\/PAS.0000000000000244","article-title":"Inflamed temporal artery: histologic findings in 354 biopsies, with clinical correlations","volume":"38","author":"Cavazza","year":"2014","journal-title":"Am J Surg Pathol."},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1002\/art.41527","article-title":"Temporal arteritis revealing antineutrophil cytoplasmic antibody-associated vasculitides: case-control study of 50 cases","author":"Delaval","year":"2020","journal-title":"Arthritis Rheumatol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.humpath.2007.08.018","article-title":"Aortitis and ascending aortic aneurysm: description of 52 cases and proposal of a histologic classification","volume":"39","author":"Burke","year":"2008","journal-title":"Hum Pathol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1097\/01.pas.0000213293.04026.ec","article-title":"Surgical pathology of noninfectious ascending aortitis: a study of 45 cases with emphasis on an isolated variant","volume":"30","author":"Miller","year":"2006","journal-title":"Am J Surg Pathol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/S0049-0172(95)80028-X","article-title":"Aortic dissection in giant-cell arteritis","volume":"25","author":"Liu","year":"1995","journal-title":"Semin Arthritis Rheum."},{"key":"B90","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s11926-020-00948-x","article-title":"Pathogenesis of giant cell arteritis and takayasu arteritis-similarities and differences","volume":"22","author":"Watanabe","year":"2020","journal-title":"Curr Rheumatol Rep."},{"key":"B91","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1172\/JCI117029","article-title":"Perforin-secreting killer cell infiltration and expression of a 65-kD heat-shock protein in aortic tissue of patients with Takayasu's arteritis","volume":"93","author":"Seko","year":"1994","journal-title":"J Clin Invest."},{"key":"B92","doi-asserted-by":"publisher","first-page":"3788","DOI":"10.1002\/art.34647","article-title":"Th1 and Th17 lymphocytes expressing CD161 are implicated in giant cell arteritis and polymyalgia rheumatica pathogenesis","volume":"64","author":"Samson","year":"2012","journal-title":"Arthritis Rheum."},{"key":"B93","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1002\/art.1780360913","article-title":"Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis","volume":"36","author":"Roche","year":"1993","journal-title":"Arthritis Rheum."},{"key":"B94","doi-asserted-by":"publisher","first-page":"a016295","DOI":"10.1101\/cshperspect.a016295","article-title":"IL-6 in inflammation, immunity, and disease","volume":"6","author":"Tanaka","year":"2014","journal-title":"Cold Spring Harb Perspect Biol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.immuni.2019.03.027","article-title":"Pleiotropy and specificity: insights from the interleukin 6 family of cytokines","volume":"50","author":"Murakami","year":"2019","journal-title":"Immunity."},{"key":"B96","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1172\/JCI117428","article-title":"Functional profile of tissue-infiltrating and circulating CD68+ cells in giant cell arteritis. Evidence for two components of the disease","volume":"94","author":"Wagner","year":"1994","journal-title":"J Clin Invest."},{"key":"B97","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.immuni.2010.05.003","article-title":"Diverse targets of the transcription factor STAT3 contribute to T cell pathogenicity and homeostasis","volume":"32","author":"Durant","year":"2010","journal-title":"Immunity"},{"key":"B98","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1002\/acr.20043","article-title":"Clinical relevance of persistently elevated circulating cytokines (tumor necrosis factor alpha and interleukin-6) in the long-term followup of patients with giant cell arteritis","volume":"62","author":"Garcia-Martinez","year":"2010","journal-title":"Arthritis Care Res"},{"key":"B99","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/art.1780400105","article-title":"Disease patterns and tissue cytokine profiles in giant cell arteritis","volume":"40","author":"Weyand","year":"1997","journal-title":"Arthritis Rheum."},{"key":"B100","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/1529-0131(199801)41:1<26::AID-ART4>3.0.CO;2-0","article-title":"Association between strong inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant cell (temporal) arteritis","volume":"41","author":"Cid","year":"1998","journal-title":"Arthritis Rheum."},{"key":"B101","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1161\/CIRCULATIONAHA.109.872903","article-title":"Th17 and Th1 T-cell responses in giant cell arteritis","volume":"121","author":"Deng","year":"2010","journal-title":"Circulation."},{"key":"B102","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1002\/art.34327","article-title":"Interleukin-21 modulates Th1 and Th17 responses in giant cell arteritis","volume":"64","author":"Terrier","year":"2012","journal-title":"Arthritis Rheum."},{"key":"B103","doi-asserted-by":"publisher","first-page":"aal3322","DOI":"10.1126\/scitranslmed.aal3322","article-title":"The microvascular niche instructs T cells in large vessel vasculitis via the VEGF-Jagged1-Notch pathway","volume":"9","author":"Wen","year":"2017","journal-title":"Sci Transl Med."},{"key":"B104","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.immuni.2015.12.003","article-title":"Th17 cell pathway in human immunity: lessons from genetics and therapeutic interventions","volume":"43","author":"Patel","year":"2015","journal-title":"Immunity."},{"key":"B105","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.ai.2018.12.001","article-title":"Multilayer regulation of CD4 T cell subset differentiation in the era of single cell genomics","volume":"141","author":"Sungnak","year":"2019","journal-title":"Adv Immunol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.3389\/fimmu.2018.01924","article-title":"T cells that help B cells in chronically inflamed tissues","volume":"9","author":"Rao","year":"2018","journal-title":"Front Immunol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1136\/annrheumdis-2012-201660","article-title":"NKG2D stimulated T-cell autoreactivity in giant cell arteritis and polymyalgia rheumatica","volume":"72","author":"Dejaco","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"B108","doi-asserted-by":"publisher","first-page":"190187","DOI":"10.1098\/rsob.190187","article-title":"Notch signalling in T cell homeostasis and differentiation","volume":"9","author":"Brandstadter","year":"2019","journal-title":"Open Biol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1161\/CIRCULATIONAHA.110.936203","article-title":"Blocking the NOTCH pathway inhibits vascular inflammation in large-vessel vasculitis","volume":"123","author":"Piggott","year":"2011","journal-title":"Circulation."},{"key":"B110","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12920-018-0376-4","article-title":"Longitudinal expression profiling of CD4+ and CD8+ cells in patients with active to quiescent giant cell arteritis","volume":"11","author":"De Smit","year":"2018","journal-title":"BMC Med Genom."},{"key":"B111","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1136\/ard.48.4.307","article-title":"Selective depletion and activation of CD8+ lymphocytes from peripheral blood of patients with polymyalgia rheumatica and giant cell arteritis","volume":"48","author":"Dasgupta","year":"1989","journal-title":"Ann Rheum Dis."},{"key":"B112","first-page":"306","article-title":"Decreased level of suppressor\/cytotoxic T cells (OKT8+) in polymyalgia rheumatica and temporal arteritis: relation to disease activity","volume":"12","author":"Elling","year":"1985","journal-title":"J Rheumatol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1006\/clin.1996.0078","article-title":"Clonally expanded CD8 T cells in patients with polymyalgia rheumatica and giant cell arteritis","volume":"79","author":"Martinez-Taboada","year":"1996","journal-title":"Clin Immunol Immunopathol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jaut.2016.05.008","article-title":"Involvement and prognosis value of CD8(+) T cells in giant cell arteritis","volume":"72","author":"Samson","year":"2016","journal-title":"J Autoimmun."},{"key":"B115","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1053\/sarh.2001.9734","article-title":"Circulating CD8+ T cells in polymyalgia rheumatica and giant cell arteritis: a review","volume":"30","author":"Martinez-Taboada","year":"2001","journal-title":"Semin Arthritis Rheum"},{"key":"B116","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1002\/art.38625","article-title":"Disturbed B cell homeostasis in newly diagnosed giant cell arteritis and polymyalgia rheumatica","volume":"66","author":"van der Geest","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"B117","doi-asserted-by":"publisher","first-page":"6553","DOI":"10.1038\/s41598-017-06826-4","article-title":"Involvement of monocyte subsets in the immunopathology of giant cell arteritis","volume":"7","author":"van Sleen","year":"2017","journal-title":"Sci Rep."},{"key":"B118","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1161\/CIRCRESAHA.118.313206","article-title":"MMP (Matrix Metalloprotease)-9-producing monocytes enable T cells to invade the vessel wall and cause vasculitis","volume":"123","author":"Watanabe","year":"2018","journal-title":"Circ Res."},{"key":"B119","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1111\/j.1600-065X.2009.00767.x","article-title":"PD-1 signaling in primary T cells","volume":"229","author":"Riley","year":"2009","journal-title":"Immunol Rev"},{"key":"B120","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1136\/annrheumdis-2012-202883","article-title":"Changes in biomarkers after therapeutic intervention in temporal arteries cultured in Matrigel: a new model for preclinical studies in giant-cell arteritis","volume":"73","author":"Corbera-Bellalta","year":"2014","journal-title":"Ann Rheum Dis."},{"key":"B121","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1084\/jem.20030850","article-title":"Activation of arterial wall dendritic cells and breakdown of self-tolerance in giant cell arteritis","volume":"199","author":"Ma-Krupa","year":"2004","journal-title":"J Exp Med."},{"key":"B122","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1097\/00007890-199903270-00018","article-title":"Human allogeneic vascular rejection after arterial transplantation and peripheral lymphoid reconstitution in severe combined immunodeficient mice","volume":"67","author":"Lorber","year":"1999","journal-title":"Transplantation."},{"key":"B123","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1096\/fj.03-0840fje","article-title":"Interferon-gamma plays a nonredundant role in mediating T cell-dependent outward vascular remodeling of allogeneic human coronary arteries","volume":"18","author":"Wang","year":"2004","journal-title":"FASEB J."},{"key":"B124","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1172\/JCI21767","article-title":"T cell-mediated vascular dysfunction of human allografts results from IFN-gamma dysregulation of NO synthase","volume":"114","author":"Koh","year":"2004","journal-title":"J Clin Invest."},{"key":"B125","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1136\/annrheumdis-2015-208371","article-title":"Blocking interferon gamma reduces expression of chemokines CXCL9, CXCL10 and CXCL11 and decreases macrophage infiltration in ex vivo cultured arteries from patients with giant cell arteritis","volume":"75","author":"Corbera-Bellalta","year":"2016","journal-title":"Ann Rheum Dis."},{"key":"B126","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1136\/jcp.44.6.497","article-title":"Analysis of adhesion molecules in the immunopathogenesis of giant cell arteritis","volume":"44","author":"Wawryk","year":"1991","journal-title":"J Clin Pathol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1002\/1529-0131(200001)43:1<184::AID-ANR23>3.0.CO","article-title":"Cell adhesion molecules in the development of inflammatory infiltrates in giant cell arteritis: inflammation-induced angiogenesis as the preferential site of leukocyte-endothelial cell interactions","volume":"43","author":"Cid","year":"2000","journal-title":"Arthritis Rheum."},{"key":"B128","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.4049\/jimmunol.161.5.2457","article-title":"IFN-gamma inhibits activation-induced expression of E- and P-selectin on endothelial cells","volume":"161","author":"Melrose","year":"1998","journal-title":"J Immunol."},{"key":"B129","doi-asserted-by":"publisher","first-page":"484","DOI":"10.7326\/0003-4819-121-7-199410010-00003","article-title":"Tissue cytokine patterns in patients with polymyalgia rheumatica and giant cell arteritis","volume":"121","author":"Weyand","year":"1994","journal-title":"Ann Intern Med."},{"key":"B130","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s001090050074","article-title":"Recognition of tissue residing antigen by T cells in vasculitic lesions of giant cell arteritis","volume":"74","author":"Martinez-Taboada","year":"1996","journal-title":"J Mol Med"},{"key":"B131","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1084\/jem.179.3.951","article-title":"Distinct vascular lesions in giant cell arteritis share identical T cell clonotypes","volume":"179","author":"Weyand","year":"1994","journal-title":"J Exp Med."},{"key":"B132","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1136\/jcp.2007.049049","article-title":"Clinical importance of the presence of giant cells in temporal arteritis","volume":"61","author":"Armstrong","year":"2008","journal-title":"J Clin Pathol."},{"key":"B133","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1136\/annrheumdis-2018-213488","article-title":"Interleukin 12 and interleukin 23 play key pathogenic roles in inflammatory and proliferative pathways in giant cell arteritis","volume":"77","author":"Conway","year":"2018","journal-title":"Ann Rheum Dis."},{"key":"B134","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1136\/annrheumdis-2012-201836","article-title":"Increased IL-17A expression in temporal artery lesions is a predictor of sustained response to glucocorticoid treatment in patients with giant-cell arteritis","volume":"72","author":"Espigol-Frigole","year":"2013","journal-title":"Ann Rheum Dis."},{"key":"B135","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1093\/rheumatology\/kev102","article-title":"Difference in the expression of IL-9 and IL-17 correlates with different histological pattern of vascular wall injury in giant cell arteritis","volume":"54","author":"Ciccia","year":"2015","journal-title":"Rheumatology."},{"key":"B136","doi-asserted-by":"publisher","first-page":"3145","DOI":"10.1084\/jem.20081661","article-title":"Interleukin (IL)-1 promotes allogeneic T cell intimal infiltration and IL-17 production in a model of human artery rejection","volume":"205","author":"Rao","year":"2008","journal-title":"J Exp Med."},{"key":"B137","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1161\/01.RES.84.9.1050","article-title":"Tissue-destructive macrophages in giant cell arteritis","volume":"84","author":"Rittner","year":"1999","journal-title":"Circ Res."},{"key":"B138","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1002\/1529-0131(199804)41:4<623::AID-ART9>3.0.CO;2-6","article-title":"Platelet-derived growth factor, intimal hyperplasia, and ischemic complications in giant cell arteritis","volume":"41","author":"Kaiser","year":"1998","journal-title":"Arthritis Rheum."},{"key":"B139","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1093\/rheumatology\/ker163","article-title":"Tissue and serum markers of inflammation during the follow-up of patients with giant-cell arteritis\u2013a prospective longitudinal study","volume":"50","author":"Visvanathan","year":"2011","journal-title":"Rheumatology"},{"key":"B140","doi-asserted-by":"publisher","first-page":"809","DOI":"10.3389\/fimmu.2018.00809","article-title":"Expression and function of IL12\/23 related cytokine subunits (p35, p40, and p19) in giant-cell arteritis lesions: contribution of p40 to Th1- and Th17-mediated inflammatory pathways","volume":"9","author":"Espigol-Frigole","year":"2018","journal-title":"Front Immunol."},{"key":"B141","doi-asserted-by":"publisher","first-page":"3637","DOI":"10.1172\/JCI38308","article-title":"An adventitial IL-6\/MCP1 amplification loop accelerates macrophage-mediated vascular inflammation leading to aortic dissection in mice","volume":"119","author":"Tieu","year":"2009","journal-title":"J Clin Invest."},{"key":"B142","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.ajpath.2019.02.006","article-title":"An overview of the derivation and function of multinucleated giant cells and their role in pathologic processes","volume":"189","author":"Brooks","year":"2019","journal-title":"Am J Pathol."},{"key":"B143","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1161\/CIRCRESAHA.108.185777","article-title":"Toll-like receptors 4 and 5 induce distinct types of vasculitis","volume":"104","author":"Deng","year":"2009","journal-title":"Circ Res."},{"key":"B144","first-page":"1925","article-title":"Interferon-gamma-producing T cells in giant cell vasculitis represent a minority of tissue-infiltrating cells and are located distant from the site of pathology","volume":"148","author":"Wagner","year":"1996","journal-title":"Am J Pathol."},{"key":"B145","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3389\/fimmu.2013.00194","article-title":"CC chemokine ligand 20 and its cognate receptor CCR6 in mucosal T cell immunology and inflammatory bowel disease: odd couple or axis of evil?","volume":"4","author":"Lee","year":"2013","journal-title":"Front Immunol."},{"key":"B146","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1136\/ard.2007.070805","article-title":"Imatinib mesylate inhibits in vitro and ex vivo biological responses related to vascular occlusion in giant cell arteritis","volume":"67","author":"Lozano","year":"2008","journal-title":"Ann Rheum Dis."},{"key":"B147","doi-asserted-by":"publisher","first-page":"604","DOI":"10.4049\/jimmunol.168.2.604","article-title":"Fractalkine is expressed by smooth muscle cells in response to IFN-gamma and TNF-alpha and is modulated by metalloproteinase activity","volume":"168","author":"Ludwig","year":"2002","journal-title":"J Immunol."},{"key":"B148","doi-asserted-by":"publisher","first-page":"E970","DOI":"10.1073\/pnas.1616848114","article-title":"Immunoinhibitory checkpoint deficiency in medium and large vessel vasculitis","volume":"114","author":"Zhang","year":"2017","journal-title":"Proc Natl Acad Sci USA."},{"key":"B149","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1136\/ard.2006.068148","article-title":"Gelatinase expression and proteolytic activity in giant-cell arteritis","volume":"66","author":"Segarra","year":"2007","journal-title":"Ann Rheum Dis."},{"key":"B150","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/35003221","article-title":"Interferon-gamma elicits arteriosclerosis in the absence of leukocytes","volume":"403","author":"Tellides","year":"2000","journal-title":"Nature."},{"key":"B151","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1136\/ard.2008.105692","article-title":"Increased expression of the endothelin system in arterial lesions from patients with giant-cell arteritis: association between elevated plasma endothelin levels and the development of ischaemic events","volume":"69","author":"Lozano","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"B152","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/S0002-9440(10)65175-9","article-title":"Formation of new vasa vasorum in vasculitis. Production of angiogenic cytokines by multinucleated giant cells","volume":"155","author":"Kaiser","year":"1999","journal-title":"Am J Pathol."},{"key":"B153","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/modpathol.2017.10","article-title":"Clinical and pathological evolution of giant cell arteritis: a prospective study of follow-up temporal artery biopsies in 40 treated patients","volume":"30","author":"Maleszewski","year":"2017","journal-title":"Mod Pathol."},{"key":"B154","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1002\/acr.21750","article-title":"Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica","volume":"64","author":"Unizony","year":"2012","journal-title":"Arthritis Care Res"},{"key":"B155","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/art.40044","article-title":"A randomized, double-blind trial of abatacept (CTLA-4Ig) for the treatment of giant cell arteritis","volume":"69","author":"Langford","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"B156","doi-asserted-by":"publisher","first-page":"621","DOI":"10.7326\/0003-4819-146-9-200705010-00004","article-title":"Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial","volume":"146","author":"Hoffman","year":"2007","journal-title":"Ann Intern Med."},{"key":"B157","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1136\/ard.2007.082115","article-title":"A double-blind placebo controlled trial of etanercept in patients with giant cell arteritis and corticosteroid side effects","volume":"67","author":"Martinez-Taboada","year":"2008","journal-title":"Ann Rheum Dis."},{"key":"B158","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1136\/annrheumdis-2013-203586","article-title":"Adalimumab for steroid sparing in patients with giant-cell arteritis: results of a multicentre randomised controlled trial","volume":"73","author":"Seror","year":"2014","journal-title":"Ann Rheum Dis."},{"key":"B159","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1186\/s13075-019-2068-7","article-title":"Significant association between clinical characteristics and changes in peripheral immuno-phenotype in large vessel vasculitis","volume":"21","author":"Matsumoto","year":"2019","journal-title":"Arthritis Res Ther."},{"key":"B160","first-page":"S21","article-title":"The critical role of IL-6 in the pathogenesis of Takayasu arteritis","volume":"34","author":"Kong","year":"2016","journal-title":"Clin Exp Rheumatol."},{"key":"B161","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.jjcc.2016.10.016","article-title":"Profiles of serum cytokine levels in Takayasu arteritis patients: potential utility as biomarkers for monitoring disease activity","volume":"70","author":"Tamura","year":"2017","journal-title":"J Cardiol."},{"key":"B162","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1002\/art.39037","article-title":"Th1 and Th17 cytokines drive inflammation in Takayasu arteritis","volume":"67","author":"Saadoun","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"B163","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.autrev.2018.01.019","article-title":"Non-glucocorticoid drugs for the treatment of Takayasu's arteritis: a systematic review and meta-analysis","volume":"17","author":"Barra","year":"2018","journal-title":"Autoimmun Rev."},{"key":"B164","first-page":"1199","article-title":"Human abdominal aortic aneurysms. Immunophenotypic analysis suggesting an immune-mediated response","volume":"137","author":"Koch","year":"1990","journal-title":"Am J Pathol."},{"key":"B165","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1161\/01.ATV.17.11.2843","article-title":"Elevated circulating levels of inflammatory cytokines in patients with abdominal aortic aneurysm","volume":"17","author":"Juvonen","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B166","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s41572-018-0030-7","article-title":"Abdominal aortic aneurysms","volume":"4","author":"Sakalihasan","year":"2018","journal-title":"Nat Rev Dis Primers."},{"key":"B167","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0021-9150(03)00282-X","article-title":"Characterisation of T and B lymphocytes infiltrating abdominal aortic aneurysms","volume":"170","author":"Ocana","year":"2003","journal-title":"Atherosclerosis."},{"key":"B168","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nrcardio.2017.52","article-title":"Monocytes and macrophages in abdominal aortic aneurysm","volume":"14","author":"Raffort","year":"2017","journal-title":"Nat Rev Cardiol."},{"key":"B169","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/S1078-5884(98)80034-8","article-title":"Chronic inflammation and elastin degradation in abdominal aortic aneurysm disease: an immunohistochemical and electron microscopic study","volume":"15","author":"Satta","year":"1998","journal-title":"Eur J Vasc Endovasc Surg."},{"key":"B170","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/S0002-9440(10)64206-X","article-title":"T(H)2 predominant immune responses prevail in human abdominal aortic aneurysm","volume":"161","author":"Schonbeck","year":"2002","journal-title":"Am J Pathol."},{"key":"B171","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41586-020-2222-z","article-title":"A. Accelerating Medicines Partnership Rheumatoid, C. Systemic Lupus Erythematosus, Siebel CW, Buckley CD, Raychaudhuri S, and Brenner MB, Notch signalling drives synovial fibroblast identity and arthritis pathology","volume":"582","author":"Wei","year":"2020","journal-title":"Nature."},{"key":"B172","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.immuni.2008.10.011","article-title":"IRF-4-binding protein inhibits interleukin-17 and interleukin-21 production by controlling the activity of IRF-4 transcription factor","volume":"29","author":"Chen","year":"2008","journal-title":"Immunity."},{"key":"B173","doi-asserted-by":"publisher","first-page":"102446","DOI":"10.1016\/j.autrev.2019.102446","article-title":"Giant-cell arteritis associated with myelodysplastic syndrome: French multicenter case control study and literature review","volume":"19","author":"Roupie","year":"2020","journal-title":"Autoimmun Rev."},{"key":"B174","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1056\/NEJMoa2026834","article-title":"Somatic mutations in UBA1 and severe adult-onset autoinflammatory disease","volume":"383","author":"Beck","year":"2020","journal-title":"N Engl J Med."},{"key":"B175","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1056\/NEJMoa2004114","article-title":"RNA identification of PRIME cells predicting rheumatoid arthritis flares","volume":"383","author":"Orange","year":"2020","journal-title":"N Engl J Med."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.623716\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T22:56:17Z","timestamp":1697928977000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.623716\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,25]]},"references-count":175,"alternative-id":["10.3389\/fimmu.2021.623716"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.623716","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,25]]},"article-number":"623716"}}